Showing results (321-330 of 555) with videos related to
Sort By:
Pageof 56
The New England Journal of Medicine|August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy GroupR P Perrillo, E R Schiff, G L Davis, et al.Pain|October 20, 2009
Absence of pain with hyperhidrosis: a new syndrome where vascular afferents may mediate cutaneous sensationDavid Bowsher, C Geoffrey Woods, Adeline K Nicholas, et al.Proceedings of the National Academy of Sciences of the United States of America|October 26, 2007
Loss of Bardet Biedl syndrome proteins causes defects in peripheral sensory innervation and functionPerciliz L Tan, Travis Barr, Peter N Inglis, et al.Hepatology (Baltimore, Md.)|November 1, 1996
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupK L Lindsay, G L Davis, E R Schiff, et al.The Review of Scientific Instruments|May 3, 2013
Production of large volume, strongly magnetized laser-produced plasmas by use of pulsed external magnetic fieldsB Albertazzi, J Béard, A Ciardi, et al.Nature Neuroscience|February 9, 2010
Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signalingJennie L Conroy, Cheng Fang, Jun Gu, et al.Journal of the American Academy of Dermatology|April 29, 2022
Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort studyN Ezeh, K Ardalan, K A Buhr, et al.Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.Computing and Software for Big Science|January 1, 2021
Allen: A High-Level Trigger on GPUs for LHCbR Aaij, J Albrecht, M Belous, et al.Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.Pageof 56